Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair | MicrobiomeTrials← Back to trialsNCT07380932
Catheter Ablation for AF in Patients With Severe Mitral Regurgitation After Successful Transcatheter Mitral-Valve Repair
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2026-09-01Est. Completion: 2031-09-01
Enrollment target: 956 participants Locations- University Hospital Cologne, Cologne, Germany
- University Heart and Vascular Center Frankfurt, Frankfurt, Germany
- Asklepios Hospital St. Georg, Hamburg, Germany
- University Hospital Münster, Münster, Germany
Other microbiome trials you might be interested in
Atrial Fibrillation (AF)
The goal of this clinical trial is to learn if the cardiac pulsed field ablation system, composed of the cardiac pulsed …
Multiple LocationsEst. completion Mar 2028
Atrial Fibrillation
DISPLAY-AF is a prospective, multicenter, single-arm post-market clinical follow-up investigation designed to evaluate w…
Avignon, FranceEst. completion Feb 2028